IDH1 and glioma: IDH1/2 mutations are early and common events in the etiopathology of astrocytomas, oligodendrogliomas, and oligoastrocytomas, and they are associated with increased DNA methylation, and termed the glioma-CpG island methylator phenotype (G-CIMP) [4].